Martingale Asset Management L P Immunity Bio, Inc. Transaction History

Martingale Asset Management L P

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$4.35 - $6.77 $11,875 - $18,482	2,730 Added 14.81%	21,166 $107,000
Q3 2022 Nov 14, 2022	BUY	$3.65 - $6.43 $18 - $32	5 Added 0.03%	18,436 $92,000
Q2 2022 Aug 11, 2022	BUY	$2.68 - $6.14 $16 - $36	6 Added 0.03%	18,431 $68,000
Q1 2022 May 12, 2022	BUY	$5.05 - $7.53 $93,046 - $138,740	18,425 New	18,425 $103,000

202

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.8B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.